Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 81.50
-2.00 (-2.40%)
Mar 24, 2026, 1:52 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5.56 billion as of March 24, 2026. Its market cap has increased by 336.38% in one year.
Market Cap
5.56B
Enterprise Value
5.48B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
81.50
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.56B, an increase of 148.37%. That is a compound annual growth rate of 56.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 5.56B | 38.94% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 6.56B |
| Savior Lifetec | 6.40B |
| CHO Pharma | 6.01B |
| AnnJi Pharmaceutical | 5.92B |
| Sinphar Pharmaceutical | 5.90B |
| Panion & Bf Biotech | 5.32B |
| Senhwa Biosciences | 5.10B |
| Pharmosa Biopharm | 5.05B |